TAK
Takeda Pharmaceutical Co Ltd ADRNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$58.95B
P/E Ratio
84.82
EPS
$0.22
Beta
0.13
52W High
$18.90
52W Low
$12.99
50-Day MA
$18.02
200-Day MA
$15.56
Dividend Yield
3.61%
Profit Margin
2.53%
Forward P/E
13.02
PEG Ratio
0.41
About Takeda Pharmaceutical Co Ltd ADR
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.
Fundamentals
| Revenue (TTM) | $4.46T |
| Gross Profit (TTM) | $2.93T |
| EBITDA | $1.27T |
| Operating Margin | 10.80% |
| Return on Equity | 1.50% |
| Return on Assets | 2.47% |
| Revenue/Share (TTM) | $1417.23 |
| Book Value | $30.51 |
| Price-to-Book | 1.23 |
| Price-to-Sales (TTM) | 0.01 |
| EV/Revenue | 3.0 |
| EV/EBITDA | 10.77 |
| Quarterly Earnings Growth (YoY) | 330.20% |
| Quarterly Revenue Growth (YoY) | 4.20% |
| Shares Outstanding | $3.16B |
| Float | $1.58B |
| % Insiders | 0.02% |
| % Institutions | 2.72% |
Historical Volatility
HV 10-Day
25.24%
HV 20-Day
23.70%
HV 30-Day
22.88%
HV 60-Day
21.63%
HV Rank
71.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($20.62 target)
3
BuyData last updated: 4/9/2026